Iyanuloluwa Olowe

Ms. Iyanuloluwa Olowe

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
JAJustice Moses K. Aheto
Justice Moses K. Aheto
IOIyanuloluwa Olowe
Iyanuloluwa Olowe
HCHo Man Theophilus Chan
Ho Man Theophilus Chan
AEAdachi Ekeh
Adachi Ekeh
BDBoubacar Dieng
Boubacar Dieng
CUChigozie Edson Utazi
Chigozie Edson Utazi
The persistence of geographic inequities in vaccination coverage often evidences the presence of zero-dose and missed communities and their vulnerabilities to vaccine-preventable diseases. These inequities were exacerbated in many places during the coronavirus disease 2019 (COVID-19) pandemic, due to severe disruptions to vaccination services. Understanding changes in zero-dose prevalence and its associated risk factors in the context of the COVID-19 pandemic is, therefore, critical to designing effective strategies to reach vulnerable populations. Using data from nationally representative household surveys conducted before the COVID-19 pandemic, in 2018, and during the pandemic, in 2021, in Nigeria, we fitted Bayesian geostatistical models to map the distribution of three vaccination coverage indicators: receipt of the first dose of diphtheria-tetanus-pertussis-containing vaccine (DTP1), the first dose of measles-containing vaccine (MCV1), and any of the four basic vaccines (bacilli Calmette-Guerin (BCG), oral polio vaccine (OPV0), DTP1, and MCV1), and the corresponding zero-dose estimates independently at a 1 × 1 km resolution and the district level during both time periods. We also explored changes in the factors associated with non-vaccination at the national and regional levels using multilevel logistic regression models. Our results revealed no increases in zero-dose prevalence due to the pandemic at the national level, although considerable increases were observed in a few districts. We found substantial subnational heterogeneities in vaccination coverage and zero-dose prevalence both before and during the pandemic, showing broadly similar patterns in both time periods. Areas with relatively higher zero-dose prevalence occurred mostly in the north and a few places in the south in both time periods. We also found consistent areas of low coverage and high zero-dose prevalence using all three zero-dose indicators, revealing the areas in greatest need. At the national level, risk factors related to socioeconomic/demographic status (e.g., maternal education), maternal access to and utilization of health services, and remoteness were strongly associated with the odds of being zero dose in both time periods, while those related to communication were mostly relevant before the pandemic. These associations were also supported at the regional level, but we additionally identified risk factors specific to zero-dose children in each region; for example, communication and cross-border migration in the northwest. Our findings can help guide tailored strategies to reduce zero-dose prevalence and boost coverage levels in Nigeria.

21 November 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
CUChigozie Edson Utazi
Chigozie Edson Utazi
IOIyanuloluwa Olowe
Iyanuloluwa Olowe
HCH. M. Theophilus Chan
H. M. Theophilus Chan
WDWINFRED DOTSE-GBORGBORTSI
WINFRED DOTSE-GBORGBORTSI
JWJohn Wagai
John Wagai
ATAndrew J. Tatem
Andrew J. Tatem
Many measles endemic countries with suboptimal coverage levels still rely on vaccination campaigns to fill immunity gaps and boost control efforts. Depending on local epidemiological patterns, national or targeted campaigns are implemented, following which post-campaign coverage surveys (PCCSs) are conducted to evaluate their performance, particularly in terms of reaching previously unvaccinated children. Due to limited resources, PCCS surveys are designed to be representative at coarse spatial scales, often masking important heterogeneities in coverage that could enhance the identification of areas of poor performance for follow-up via routine immunization strategies. Here, we undertake geospatial analyses of the 2021 measles PCCS in Nigeria to map indicators of coverage measuring the individual and combined performance of the campaign and routine immunization (RI) at 1 × 1 km resolution and the ward and district levels in 13 states. Using additional geospatial datasets, we also produced estimates of numbers of unvaccinated children during the campaign and numbers of measles-containing vaccine (MCV) zero-dose children before and after the campaign at these levels and within health facility catchment areas. Our study revealed that although the campaign reduced the numbers of MCV zero-dose children in all the districts, areas of suboptimal campaign and RI performance with considerable numbers of zero-dose children remained. Our analyses further identified wards and health facility catchment areas with higher numbers of unvaccinated children within these areas. Our outputs provide a robust evidence base to plan and implement follow-up RI strategies and to guide future campaigns at flexible and operationally relevant spatial scales.

8 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
CUChigozie Edson Utazi
Chigozie Edson Utazi
IOIyanuloluwa Olowe
Iyanuloluwa Olowe
TCTheo H. M. Chan
Theo H. M. Chan
WDWinfred Dotse-Gborgortsi
Winfred Dotse-Gborgortsi
JWJohn Wagai
John Wagai
ATAndrew J Tatem
Andrew J Tatem
Many measles endemic countries with suboptimal coverage levels still rely on vaccination campaigns to fill immunity gaps and boost control efforts. Depending on local epidemiological patterns, national or targeted campaigns are implemented, following which post-campaign coverage surveys (PCCSs) are conducted to evaluate their performance, particularly in terms of reaching previously unvaccinated children. Due to limited resources, PCCS surveys are designed to be representative at coarse spatial scales, often masking important heterogeneities in coverage that could enhance the identification of areas of poor performance for follow up via routine immunization strategies. Here, we undertake geospatial analyses of the 2021 measles PCCS in Nigeria to map indicators of coverage measuring the individual and combined performance of the campaign and routine immunization (RI) at 1x1 km resolution and the ward and district levels in 13 states. Using additional geospatial data sets, we also produced estimates of numbers of unvaccinated children during the campaign and numbers of measles-containing vaccine (MCV) zero-dose children before and after the campaign at these levels and within health facility catchment areas. Our study revealed that although the campaign reduced the numbers of MCV zero-dose children in all the districts, areas of suboptimal campaign and RI performance with considerable numbers of zero-dose children remained. Our analyses further identified wards and health facility catchment areas with higher numbers of unvaccinated children within these areas. Our outputs provide a robust evidence base to plan and implement follow-up RI strategies and to guide future campaigns at flexible and operationally relevant spatial scales.

1 November 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
JAJustice Moses K. Aheto
Justice Moses K. Aheto
IOIyanuloluwa Olowe
Iyanuloluwa Olowe
HCHo Man Theophilus Chan
Ho Man Theophilus Chan
AEAdachi Ekeh
Adachi Ekeh
BDBoubacar Dieng
Boubacar Dieng
CUChigozie Edson Utazi
Chigozie Edson Utazi
The persistence of geographic inequities in vaccination coverage often evidences the presence of zero-dose and missed communities and vulnerabilities to vaccine-preventable diseases. These inequities were exacerbated in many places during the COVID-19 pandemic, due to severe disruptions to vaccination services. Understanding changes in zero-dose prevalence and associated risk factors in the context of the COVID-19 pandemic is, therefore, critical to designing effective strategies to reach vulnerable populations. Using data from nationally representative household surveys conducted before the COVID-19 pandemic in 2018 and during the pandemic in 2021 in Nigeria, we fitted Bayesian geostatistical models to map the distribution of three vaccination coverage indicators: receipt of DTP1, MCV1 and any of the four basic vaccines (BCG, OPV0, DTP1 and MCV1), and corresponding zero-dose estimates independently at 1x1 km resolution and the district level during both time periods. We also explored changes in the factors associated with non-vaccination at the national and regional levels using multilevel logistic regression models. Our results revealed no increases in zero-dose prevalence due to the pandemic at the national level, although considerable increases were observed in a few districts. We found substantial subnational heterogeneities in vaccination coverage and zero-dose prevalence both before and during the pandemic, showing broadly similar patterns in both time periods. Areas with relatively higher zero-dose prevalence occurred mostly in the north and a few places in the south in both time periods. We also found consistent areas of low coverage and high zero-dose prevalence using all three zero-dose indicators, revealing areas in greatest need. At the national level, risk factors related to socioeconomic/ demographic status (e.g., maternal education), maternal access to and utilization of health services and remoteness were strongly associated with the odds of zero dose in both time periods, while those related to communication were mostly relevant before the pandemic. These associations were also supported at the regional level, but we additionally identified risk factors specific to zero dose in each region; for example, communication and cross-border migration in the northwest. Our findings can help guide tailored strategies to reduce zero-dose prevalence and boost coverage levels in Nigeria.

17 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
CUChigozie Edson Utazi
Chigozie Edson Utazi
SCSomnath Chaudhuri
Somnath Chaudhuri
OWOghenebrume Wariri
Oghenebrume Wariri
IOIyanuloluwa Olowe
Iyanuloluwa Olowe
MMMohamed Megheib
Mohamed Megheib
ATAndrew Tatem
Andrew Tatem
High-resolution maps of vaccination coverage are valuable for uncovering heterogeneities in coverage to inform vaccine delivery strategies. Coverage maps stratified by age can reveal additional heterogeneities in the timeliness of vaccination and critical immunity gaps among birth cohorts. Here, we propose a spatially varying coefficient model relying on a Bayesian approach for age-structured mapping of vaccination coverage using geolocated individual level household survey and geospatial covariate data. Our flexible modelling framework includes parameterizations capturing spatial (non-)stationarity in differences in coverage between age groups, as well as a modification to allow coverage mapping for singe age points through the inclusion of a smoother over age. The proposed models are fitted using the INLA-SPDE approach implemented in the inlabru package in R. We choose between competing model parameterizations by examining their out-of-sample predictive performance via cross-validation and using Bayesian model choice criteria. The methodology is applied to age-structured mapping of measles vaccination coverage in Cote d’Ivoire using the 2021 Demographic and Health Survey. Our results reveal a significant delay in measles vaccination in the first year of life and substantial spatial differences in coverage by age, highlighting the need for targeted interventions to achieve equity and attain vaccine-derived immunity goals.

26 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
CUChigozie Edson Utazi
Chigozie Edson Utazi
OYOrtis Yankey
Ortis Yankey
SCSomnath Chaudhuri
Somnath Chaudhuri
IOIyanuloluwa Olowe
Iyanuloluwa Olowe
M. Carolina DanovaroM. Carolina Danovaro
M. Carolina Danovaro
ATAndrew Tatem
Andrew Tatem
Recently, there has been a growing interest in the production of high-resolution maps of vaccination coverage. These maps have been useful for uncovering geographic inequities in coverage and improving targeting of interventions to reach marginalized populations. Different methodological approaches have been developed for producing these maps using mostly geolocated household survey data and geospatial covariate information. However, it remains unclear how much the predicted coverage maps produced by the various methods differ, and which methods yield more reliable estimates. Here, we explore the predictive performance of these methods and resulting implications for spatial prioritization to fill this gap. Using Nigeria Demographic and Health Survey as a case study, we generate 1x1 km and district level maps of indicators of vaccination coverage using geostatistical, machine learning (ML) and hybrid methods and evaluate predictive performance via cross-validation. Our results show similar predictive performance for five of the seven methods investigated, although two geostatistical approaches are the best methods. The worst-performing methods are two ML approaches. We find marked differences in spatial prioritization using these methods, which could potentially result in missing important underserved populations, although broad similarities exist. Our study can help guide map production for other health and development metrics.